The consequences of Ozempic | RNZ Interview - podcast episode cover

The consequences of Ozempic | RNZ Interview

Jul 01, 202516 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Grant Schofield interview with radio New Zealand. On, Tuesday 1 July 2025, New Zealanders will be able to access weight-loss drug Wegovy by prescription in their local pharmacies.

Professor of Public Health Grant Scofield joins Emile Donovan to discuss the effectiveness of weight-loss drugs and whether the funding settings are right - with a month of Wegovy estimated to cost $450 to $600 per month.

For the best experience, listen in Metacast app for iOS or Android